APP下载

贾彦焘主任基于调气健脾法治疗转移性肝癌临证经验

2021-05-21郭红磊贾彦焘

中国民族民间医药·下半月 2021年2期

郭红磊 贾彦焘

【摘 要】 介绍贾彦焘主任治疗转移性肝癌的经验。贾彦焘主任认为调气健脾应当贯穿转移性肝癌治疗的全过程,且健脾不可单纯补脾,应辅以调气之品,调补结合,再辅以活血化瘀、疏肝行气、利水渗湿等治法,兼顾多种兼证的调理,可以获得良好疗效。现通过分析以此法为核心治疗转移性肝癌,在影像学检查中获明显成效的验案一则,希冀体悟中医治疗的临床辨证思维及用药经验,并为中医治疗转移性肝癌的治疗提供新思路。

【关键词】 转移性肝癌;调气健脾;中医药疗法;名师经验;贾彦焘

【中图分类号】R249.2/.1 【文献标志码】 A【文章编号】1007-8517(2021)04-0074-03

Abstract:To introduce the experience of Director Jia Yantao in the treatment of metastatic liver cancer. Director Jia Yantao believes that regulating Qi and invigorating spleen should run through the whole process of treatment of metastatic liver cancer, and invigorating spleen should not only supplement spleen, but also be supplemented by regulating Qi products, combined with the treatment of activating blood circulation and removing blood stasis, soothing liver and promoting qi, diuresis and dampness. Through the analysis of this method as the core treatment of metastatic liver cancer, we hope to understand the clinical dialectical thinking and medication experience of TCM treatment, and provide new ideas for the treatment of metastatic liver cancer by TCM.

Keywords:Metastatic Liver Cancer; Regulating Qi and Invigorating Spleen; TCM Therapy; Experience of Famous Teachers; Jia Yantao

贾彦焘主任为天津中医药大学第一附属医院肿瘤科主任医师,硕士生导师,临证30余年,擅长应用中医药特色疗法,辨证论治多种恶性肿瘤。对转移性肝癌,缩小肿物体积及治疗肿瘤并发症有丰富的经验及独特的见解。

转移性肝癌又称继发性肝癌,在临床上较常见,是影响肝癌临床疗效的主要因素之一[1-2]。身体各个部位的肿瘤可分别通过门静脉、肝动脉、淋巴转移和直接蔓延转移至肝脏。患者生存期短,预后差,据文献报道,转移性肝癌的5年生存率介于15%~50%[3]。死于恶性肿瘤的患者中,40%存在肝转移[4]。在治疗方面,通过肝部分切除术有可能使转移性肝癌患者得到治愈,但是,肝癌确诊后适于手术切除者仅为20%~30%[4]。中期肝癌经综合微创术后肝外转移率高,其中,肺是最常见的转移器官,占肝外转移的39.5%~53.8%[5]。射频消融、放疗、化疗、免疫治疗等治疗方法日新月异,而中医在减毒增效、提高患者生存质量方面有明显优势。……

登录APP查看全文